GILD vs MIAX · P/E 18, rev $7.80B vs P/E 30, rev $1.36B
Gilead Sciences Inc (GILD) versus Miami International Holdings, Inc. (MIAX) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US. It is led by Daniel P. O'Day.
Miami International Holdings, Inc. (MIAX) is a capital markets company listed on NYSE.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported MIAX revenue for 2025-12-31 was $1.36B. Net income was -$70.0M. Revenue was up 19.6% from 2024-12-31 to 2025-12-31. MIAX currently screens at market cap $3.63B and trailing P/E 29.6.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. MIAX currently screens at market cap $3.63B and trailing P/E 29.6.
Not investment advice. Open the GILD and MIAX stock pages for the full models.
Not investment advice.